IP Library Granted Patent US 11,098,298
Granted Patent B2
US 11,098,298 · App. 16/400,520 · Granted Aug 24, 2021

Method for recombinant production of horseshoe crab Factor C protein in protozoa

Inventors: Bernd Buchberger (Zeitlarn/Laub, DE); Holger Grallert (Weilheim/Obb., DE); Sonja Molinaro (Weilheim/Obb., DE)
Assignee: BIOMÉRIEUX DEUTSCHLAND GMBH
C12N9/6424C12N9/6408C12Y304/21084G01N33/579C12N2800/10C12N2800/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,098,298
App. No.
16/400,520
Granted
Aug 24, 2021
Kind
B2
Abstract

The present invention provides a novel method for the recombinant production of Factor C protein from horseshoe crab using a parasitic protozoan expressing the Factor C protein. In particular, the present invention provides a parasitic protozoan host cell harbouring a polynucleotide encoding horseshoe crab Factor C protein, and a method for producing Factor C protein comprising culturing said parasitic protozoan host cell under conditions such that the cells express the horseshoe crab Factor C protein. Furthermore, the present invention provides recombinant Factor C protein produced by the novel method and its use in the detection and/or removal of endotoxin.

Claims (12)

1. A method for detecting endotoxin in a sample suspected of containing endotoxin, the method comprising

a) obtaining a recombinant horseshoe crab Factor C prepared by culturing a parasitic protozoan comprising a polynucleotide encoding horseshoe crab Factor C protein, said protozoan expressing a two-chain zymogen form of horseshoe crab Factor C protein having a molecular weight of about 102 kDa as determined by SDS-PAGE under non-reducing conditions, said zymogen being rendered enzymatically active upon contacting lipopolysaccharide and recovering the recombinant Factor C; and

b) contacting the sample to be assayed for the presence of endotoxin with the recombinant horseshoe crab Factor C by measuring serine protease activity of the recombinant Factor C.

2. The method of claim 1 , wherein the parasitic protozoan is a member of the order Trypanosomatida.

3. The method of claim 2 , wherein the parasitic protozoan is a member of the genus Leishmania.

4. The method of claim 3 , wherein the parasitic protozoan is Leishmania tarentolae.

5. The method of claim 1 , wherein said polynucleotide encodes Factor C protein from Limulus polyphemus, Carcinoscorpius rotundicauda, Tachypleus tridentatus , or Tachypleus gigas.

6. The method of claim 1 , wherein enzymatic activity of the recombinant Factor C is measured through the use of a chromogenic or fluorogenic substrate followed by chromogenic or fluorogenic detection.

7. The method of claim 6 , wherein the substrate is a chromogenic peptidyl-pNA substrate or fluorogenic peptidyl-AMC, peptidyl-AFC, or peptidyl-MCA substrates.

8. The method of claim 7 , wherein the substrate is N-t-Boc-VPR-MCA, N-t-BocVPR-AMC, Mu-VPR-AFC or Boc-VPR-pNA.

9. The method of claim 1 , wherein the expressed Factor C protein is accumulated in the cell culture medium.

10. The method of claim 1 , wherein said polynucleotide encodes Factor C protein having the amino acid sequence of SEQ ID NO: 4.

Assignments (1)
MERGER Recorded Mar 12, 2021
From: HYGLOS INVEST GMBH
To: BIOMÉRIEUX DEUTSCHLAND GMBH
Reel/Frame 055574/0709 →